Tempest Therapeutics Stock (NASDAQ: TPST) stock price, news, charts, stock research, profile.
You can purchase shares of Tempest Therapeutics (NASDAQ:TPST) through any online brokerage.
Other companies in Tempest Therapeutics’s space includes: Fortress Biotech (NASDAQ:FBIO), Estrella Immunopharma (NASDAQ:ESLA), Acurx Pharmaceuticals (NASDAQ:ACXP), Curis (NASDAQ:CRIS) and T2 Biosystems (NASDAQ:TTOO).
Tempest Therapeutics has a consensus price target of $19.40.
The stock price for Tempest Therapeutics (NASDAQ: TPST) is $1.3 last updated September 25, 2024 at 3:23 PM EDT.
There are no upcoming dividends for Tempest Therapeutics.
Tempest Therapeutics’s Q3 earnings are confirmed for Wednesday, November 6, 2024.
There is no upcoming split for Tempest Therapeutics.
Tempest Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.